Ensho Therapeutics, Inc., 2026-10-15
A new SEC Form D private-offering notice from Woodcliff Lake, NJ, a $15,604,179 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Clinical-stage biopharmaceutical company developing oral small molecule therapies, including an alpha4beta7 integrin antagonist, for inflammatory bowel disease.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Tru Fit Tax & Planning Inc., 2026-10-23, $2M, Rumson, NJ
- Immorta Bio, Inc., 2026-10-16, $5M, Miami Beach, FL
- Memazing, Inc., 2026-10-16, $26.2M, Princeton, NJ
- J3 BIOSCIENCE, INC., 2026-10-16, $50K, Salt Lake City, UT
- Less Noise More Signal Inc., 2026-10-14, $2M, Millburn, NJ
- Immuno Cancer Biotherapeutics, Inc., 2026-10-15, Canton, SD
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.